Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Filings indexed 951 across all filing types
Latest filing 2010-11-08 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings
2010-11-08 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Q2 2011
2010-11-04 English
Earnings Release 2010
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 4, 2010, by Oculus Innovative Sciences, Inc. It announces the issuance of a press release containing financial results for the fiscal quarter ended September 30, 2010. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The length is under 5,000 characters and the document serves as a current report announcing financial results rather than the full quarterly report. According to the classification rules, such a document is best classified as an Earnings Release (ER) since it announces quarterly financial results highlights via a press release.
2010-11-04 English
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC responding to comments on a previously filed Form 10-K for the fiscal year ended March 31, 2010. It is a certification by the COO and General Counsel regarding the adequacy and accuracy of the disclosure in the Form 10-K. The document does not contain the actual Form 10-K report or financial data but is a response and certification related to it. The document length is only 1500 characters, indicating it is a short letter rather than a full report. According to the Certification Rule, such officer certifications or attestation letters should be classified as Regulatory Filings (RNS), not as the report itself (10-K).
2010-10-29 English
Regulatory Filings 2010
Regulatory Filings
2010-09-30 English
Declaration of Voting Results & Voting Rights Announcements 2010
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated September 13, 2010. It includes detailed voting results from the 2010 Annual Meeting of Stockholders, including election of directors, approval of a stock incentive plan, and ratification of the appointment of an independent auditor. It also describes a Continuous Offering Program Agreement related to the sale of common stock. The presence of detailed voting results from the Annual Meeting clearly indicates this is a Declaration of Voting Results & Voting Rights Announcement. The document is not an Annual Report, Earnings Release, or Proxy Statement, but specifically reports the outcomes of shareholder votes. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements). The document length and content support a high confidence score.
2010-09-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.